Penel, N; Blay, JY; Wallet, J; Mir, O; Italiano, A; Bertucci, F; Piperno-Neumann, S; Brodowicz, T; Bompas, E; Liegl-Atzwanger, B; Chevreau, CM; Ray-Coquard, L; Taieb, S; Decoupigny, E; Le Deley, MC; Le Cesne, A.
Prior exposure to pazopanib (PAZ) did not minor efficacy of regorafenib (REG) in non-adipocytic soft tissue sarcoma patients (pts)
ANN ONCOL. 2019; 30: 695-695.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN.
[Oral Communication]
Web of Science